Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 762 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Ziopharm completes enrollment in PICASSO 3 trial

The randomized, double-blind, placebo-controlled Phase 3 study is designed to evaluate the safety and efficacy of palifosfamide and doxorubicin compared to doxorubicin and placebo, with no crossover between

Agendia unveils ColoPrint microarray signature

The ColoPrint assay provides critical additional information for treatment decisions for stage II colon cancer patients who have undergone surgery. ColoPrint also helps in eliminating the gray area